AMH
AUPH icon

Apollo Management Holdings’s Aurinia Pharmaceuticals AUPH Stock Holding History

Apollo Management Holdings’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,795
Closed -$72K – 267
2022
Q1 		$72K Buy
+5,795
New +$89.6K ﹤0.01% 313

Other funds holding AUPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Apollo Management Holdings's AUPH Position: Q2 2022 in Review

Apollo Management Holdings sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2022, closing a stake of 5,795 shares — an estimated $72K sold.

Apollo Management Holdings first reported a position in AUPH in Q1 2022 and held it in 1 quarter. The position peaked at $72K in Q1 2022. 199 funds tracked by Wall St. Rank hold AUPH as of Q2 2022.

  • Apollo Management Holdings reported no remaining Aurinia Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Apollo Management Holdings sold 5,795 Aurinia Pharmaceuticals shares in Q2 2022, an estimated $72K.
  • Apollo Management Holdings first reported a position in Aurinia Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • Apollo Management Holdings's Aurinia Pharmaceuticals position peaked at $72K in Q1 2022.
  • 199 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2022.

Based on Apollo Management Holdings's 13F filing for Q2 2022, filed 16 Aug 2022.